Insmed

Program Patents

Insmed Incorporated owns or licenses the following patents and patent applications in the United States and counterparts in certain foreign jurisdictions for the following products.

Amikacin Liposome Inhalation Suspension
(ALIS or Arikayce®)

Patent No. or Publication No. Patent Expiration
U.S. Patent No. 7,718,189 06/06/2025
U.S. Patent No. 8,226,975 08/15/2028
U.S. Patent No. 8,632,804 12/05/2026
U.S. Patent No. 8,642,075 12/05/2026
U.S. Patent No. 8,679,532 12/05/2026
U.S. Patent No. 9,566,234 01/18/2034
U.S. Patent No. 9,827,317 04/08/2024
U.S. Patent No. 9,895,385 05/15/2035
U.S. Patent No. 10,251,900 05/15/2035
U.S. Patent No. 10,751,355 05/15/2035
U.S. Patent No. 10,828,314 05/15/2035
U.S. Patent No. 11,395,830 05/15/2035
U.S. Patent No. 11,446,318 05/15/2035
U.S. Patent No. 12,016,873 05/15/2035
U.S. Patent No. 12,168,021 05/15/2035
U.S. Patent No. 12,168,022 05/15/2035
PCT Publication No. WO 2022/047292 08/30/2041

Brensocatib (BRINSUPRI™)

Patent No. or Publication No. Patent Expiration
U.S. Patent No. 9,522,894 01/23/2035
U.S. Patent No. 9,815,805 01/23/2035
U.S. Patent No. 10,287,258 01/23/2035
U.S. Patent No. 10,669,245 01/23/2035
U.S. Patent No. 11,117,874 01/23/2035
U.S. Patent No. 11,655,221 01/23/2035
U.S. Patent No. 11,655,222 01/23/2035
U.S. Patent No. 11,655,223 01/23/2035
U.S. Patent No. 11,655,224 01/23/2035
U.S. Patent No. 11,667,615 01/23/2035
U.S. Patent No. 11,673,871 01/23/2035
U.S. Patent No. 11,673,872 01/23/2035
U.S. Patent No. 11,680,049 01/23/2035
U.S. Patent No. 11,773,069 01/23/2035
U.S. Patent No. 11,814,359 01/23/2035
U.S. Patent No. 12,054,465 01/23/2035
U.S. Patent No. 12,059,424 03/01/2039
U.S. Patent No. 12,201,638 03/01/2039
PCT Publication No. WO 2015/110826 01/23/2035
PCT Publication No. WO 2019/166626 03/01/2039